Form 4: Revolution Medicines COO Sells Shares
Insider Transaction (Form 4)
Margaret A Horn, Chief Operating Officer of Revolution Medicines, Inc., sold 4,967 shares of common stock on September 16, 2026.
Summary
- Open-market sale: disposed of 76 Common Stock at $195.01 ($14,821) on September 16, 2026; holds 154,571 after (Direct).
- Open-market sale: disposed of 4,891 Common Stock at $199.30 ($974,792) on September 16, 2026; holds 149,680 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $989,613 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Margaret A Horn — Officer (Chief Operating Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 76 | $195 | $14.8K | 154,571 |
| 2026-09-16 | Open-market sale | Common Stock | 4,891 | $199 | $974.8K | 149,680 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (76 shares) |
| 2026-09-16 | Open-market sale (4,891 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Margaret A Horn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.